Maximus, Inc. (NYSE:MMS) General Counsel David Francis sold 2,000 shares of the business’s stock in a transaction on Friday, August 18th. The stock was sold at an average price of $58.89, for a total value of $117,780.00. Following the completion of the transaction, the general counsel now directly owns 13,716 shares of the company’s stock, valued at $807,735.24. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

David Francis also recently made the following trade(s):

  • On Friday, July 14th, David Francis sold 1,000 shares of Maximus stock. The stock was sold at an average price of $60.46, for a total value of $60,460.00.
  • On Friday, June 23rd, David Francis sold 1,000 shares of Maximus stock. The stock was sold at an average price of $63.15, for a total value of $63,150.00.
  • On Friday, June 2nd, David Francis sold 1,000 shares of Maximus stock. The stock was sold at an average price of $62.70, for a total value of $62,700.00.

Maximus, Inc. (MMS) traded up 0.22% during trading on Monday, reaching $59.43. The company had a trading volume of 129,181 shares. Maximus, Inc. has a 52-week low of $43.69 and a 52-week high of $64.97. The stock has a market cap of $3.86 billion, a PE ratio of 19.05 and a beta of 1.39. The company has a 50-day moving average price of $60.78 and a 200 day moving average price of $61.00.

Maximus (NYSE:MMS) last posted its quarterly earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.76 by $0.03. The business had revenue of $600.40 million for the quarter, compared to analyst estimates of $614.12 million. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The firm’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same quarter last year, the business posted $0.79 EPS. On average, analysts anticipate that Maximus, Inc. will post $3.12 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, August 31st. Investors of record on Tuesday, August 15th will be paid a $0.045 dividend. This represents a $0.18 annualized dividend and a yield of 0.30%. The ex-dividend date is Friday, August 11th. Maximus’s payout ratio is 5.73%.

WARNING: “Maximus, Inc. (MMS) General Counsel Sells $117,780.00 in Stock” was first posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was copied illegally and reposted in violation of U.S. & international copyright & trademark law. The original version of this piece can be viewed at https://www.americanbankingnews.com/2017/08/21/maximus-inc-mms-general-counsel-sells-117780-00-in-stock.html.

A number of institutional investors have recently modified their holdings of MMS. American International Group Inc. increased its position in Maximus by 4.1% in the first quarter. American International Group Inc. now owns 166,652 shares of the health services provider’s stock valued at $10,366,000 after buying an additional 6,634 shares during the last quarter. Louisiana State Employees Retirement System increased its position in shares of Maximus by 2.5% in the first quarter. Louisiana State Employees Retirement System now owns 16,400 shares of the health services provider’s stock worth $1,020,000 after buying an additional 400 shares in the last quarter. Navellier & Associates Inc increased its position in shares of Maximus by 10.9% in the first quarter. Navellier & Associates Inc now owns 8,737 shares of the health services provider’s stock worth $543,000 after buying an additional 856 shares in the last quarter. OppenheimerFunds Inc. increased its position in shares of Maximus by 19.5% in the first quarter. OppenheimerFunds Inc. now owns 11,010 shares of the health services provider’s stock worth $685,000 after buying an additional 1,793 shares in the last quarter. Finally, Advantus Capital Management Inc increased its position in shares of Maximus by 3.1% in the first quarter. Advantus Capital Management Inc now owns 8,298 shares of the health services provider’s stock worth $516,000 after buying an additional 248 shares in the last quarter. 97.20% of the stock is owned by institutional investors and hedge funds.

A number of research firms have recently weighed in on MMS. Zacks Investment Research cut Maximus from a “buy” rating to a “hold” rating in a report on Wednesday, August 9th. Maxim Group set a $66.00 target price on Maximus and gave the company a “hold” rating in a research note on Thursday, August 3rd. BidaskClub lowered Maximus from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. Canaccord Genuity lowered Maximus from a “buy” rating to a “hold” rating and set a $62.00 target price for the company. in a research note on Tuesday, July 4th. Finally, KeyCorp reiterated a “sector weight” rating on shares of Maximus in a research note on Thursday, May 25th. One analyst has rated the stock with a sell rating and eight have given a hold rating to the company. Maximus currently has an average rating of “Hold” and an average price target of $62.17.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.